Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.639168
Abstract: Background Pulmonary sarcomatoid cancer (PSC) is a very rare subtype of poorly differentiated non-small-lung-cancer (NSCLC) with very poor prognosis. To date, the optimal treatment for PSC has not been elucidated, and the efficacy of anlotinib…
read more here.
Keywords:
sarcomatoid cancer;
psc;
anlotinib combined;
pulmonary sarcomatoid ... See more keywords